MicroRNAs and PARP: Co-Conspirators With ROS in Pulmonary Hypertension. Focus on “miR-223 Reverses Experimental Pulmonary Arterial Hypertension”: Fig. 1.

American Journal of Physiology - Cell Physiology - United States
doi 10.1152/ajpcell.00209.2015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

miR-223 Reverses Experimental Pulmonary Arterial Hypertension

American Journal of Physiology - Cell Physiology
PhysiologyCell Biology
2015English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Pathophysiology

European Respiratory Review
PulmonaryRespiratory Medicine
2010English

Other Causes of Pulmonary Arterial Hypertension: Pulmonary Veno-Occlusive Disease, Pulmonary Capillary Hemangiomatosis, Porto-Pulmonary Hypertension, HIV- Associated Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

A Focus on Macitentan in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

A Focus on Riociguat in the Treatment of Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Heritable Pulmonary Arterial Hypertension

2020English

Pregnancy and Pulmonary Arterial Hypertension

2011English

Arrhythmias in Pulmonary Arterial Hypertension

Journal of Congenital Cardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy